In the in vitro model of non‐inflammatory steatosis, β‐gal or p53 protein levels were significantly increased in the p16‐overexpressing IMR‐90 and A549 cells compared to the controls (Supporting Information Figure S5A–D). The gene discussed is CDKN2A; the disease is steatosis.